Tags

Type your tag names separated by a space and hit enter

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research.
Epidemiology. 2011 Sep; 22(5):629-31.E

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Madigan D
Department of Statistics, Columbia University, New York, NY 10027, USA. madigan@stat.columbia.edu
Ryan P
No affiliation info available

MeSH

Comparative Effectiveness ResearchDrug EvaluationEmpirical ResearchEpidemiologic MethodsObservationPharmacoepidemiologyProduct Surveillance, PostmarketingUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21811110

Citation

Madigan, David, and Patrick Ryan. "What Can We Really Learn From Observational Studies?: the Need for Empirical Assessment of Methodology for Active Drug Safety Surveillance and Comparative Effectiveness Research." Epidemiology (Cambridge, Mass.), vol. 22, no. 5, 2011, pp. 629-31.
Madigan D, Ryan P. What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research. Epidemiology. 2011;22(5):629-31.
Madigan, D., & Ryan, P. (2011). What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research. Epidemiology (Cambridge, Mass.), 22(5), 629-31. https://doi.org/10.1097/EDE.0b013e318228ca1d
Madigan D, Ryan P. What Can We Really Learn From Observational Studies?: the Need for Empirical Assessment of Methodology for Active Drug Safety Surveillance and Comparative Effectiveness Research. Epidemiology. 2011;22(5):629-31. PubMed PMID: 21811110.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research. AU - Madigan,David, AU - Ryan,Patrick, PY - 2011/8/4/entrez PY - 2011/8/4/pubmed PY - 2012/3/8/medline SP - 629 EP - 31 JF - Epidemiology (Cambridge, Mass.) JO - Epidemiology VL - 22 IS - 5 SN - 1531-5487 UR - https://www.unboundmedicine.com/medline/citation/21811110/What_can_we_really_learn_from_observational_studies:_the_need_for_empirical_assessment_of_methodology_for_active_drug_safety_surveillance_and_comparative_effectiveness_research_ L2 - http://dx.doi.org/10.1097/EDE.0b013e318228ca1d DB - PRIME DP - Unbound Medicine ER -